Global Xerostomia Therapeutics Market Forecast 2024-2030: By Offering (OTC, Prescription), Drug Type (Dentifrices, Salivary Stimulants, Salivary Substitutes), Distribution Channel

Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Xerostomia Therapeutics Market by Offering (OTC, Prescription), Drug Type (Dentifrices, Salivary Stimulants, Salivary Substitutes), Distribution Channel - Forecast 2024-2030" report has been added to's offering.

The Xerostomia Therapeutics Market size was estimated at USD 2.24 billion in 2023, USD 2.35 billion in 2024, and is expected to grow at a CAGR of 4.60% to reach USD 3.07 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Xerostomia Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Xerostomia Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

Key Topics Covered


  • Increasing incidences of xerostomia in the aging population
  • Growing awareness about xerostomia-related products
  • Ongoing research and development for the development of efficient products for xerostomia


  • High cost of medications and medical treatments associated with xerostomia therapies


  • Strict regulations pertaining to marketing and selling xerostomia-related products

Key Attributes

Report AttributeDetails
No. of Pages185
Forecast Period2024 - 2030
Estimated Market Value (USD) in 2024$2.35 Billion
Forecasted Market Value (USD) by 2030$3.07 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal

Companies Mentioned

  • 3M Company
  • Advanz Pharma Corp.
  • Bausch Health Companies Inc.
  • Bio Cosmetics Laboratories, S.L.
  • Biodexa Pharmaceuticals PLC
  • CCMed Ltd.
  • Chattem, Inc. by Sanofi S.A.
  • Cipla Ltd.
  • Colgate-Palmolive Company
  • Cyclacel Pharmaceuticals, Inc.
  • Forward Science
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • ICPA Health Products Ltd
  • Lupin Limited
  • Mission Pharmacal Company
  • Parnell Pharmaceuticals Inc.
  • Perrigo Company plc
  • Pharmascience Inc.
  • Quest Products Inc.
  • Saliwell Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Synedgen Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Xerostomia Therapeutics Market

Contact Data